Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors
oleh: Franck E. Nicolini, H. Jean Khoury, Luke Akard, Delphine Rea, Hagop Kantarjian, Michele Baccarani, Janis Leonoudakis, Adam Craig, Annie-Claude Benichou, Jorge Cortes
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2013-07-01 |
Deskripsi
No description available for this item.